Ascletis Pharma to Host Informative Obesity Portfolio Webinar
Ascletis Pharma Inc. (HKEX:1672, "Ascletis") is excited to announce its upcoming Obesity Portfolio Webinar scheduled for April 2, 2025. The webinar is set to take place from 9:00 a.m. to 10:30 a.m. Eastern Time. This virtual event aims to provide in-depth insights into Ascletis’ innovative approaches to obesity treatment.
Details of the Webinar
The webinar will showcase significant developments concerning Ascletis’ obesity portfolio. Participants can expect detailed discussions on ASC30, an exciting clinical stage GLP-1R biased small molecule agonist. This molecule is being developed for both daily oral tablet and monthly subcutaneous injection administration, presenting promising pathways for treatment.
Presenters and Q&A Session
Dr. Jinzi Jason Wu, the Founder, Chairman, and CEO of Ascletis, along with John Gargiulo, the Chief Business Officer, will lead the presentation. Following the main presentation, there will be a Q&A session where attendees can engage directly with the presenters.
How to Register for the Webinar
Interested individuals can register for the event to ensure their participation. A simple registration process will grant access to the virtual presentation. If you wish to attend this informative session, please secure your spot by registering.
Accessing the Replay
For those unable to attend the webinar live, an archived replay of the session will be made available for 30 days post-event. This will allow attendees to revisit the insightful discussions and expert presentations at their convenience.
About Ascletis Pharma Inc.
Ascletis is a pioneering biotech company listed on the Hong Kong Stock Exchange (1672.HK). The organization is driven by a commitment to research and development, concentrated on addressing significant unmet medical needs in two primary areas: metabolic diseases and viral diseases. With a robust drug development pipeline, Ascletis is dedicated to advancing various clinical-stage candidates aimed at improving patient outcomes globally.
Company Contact Information
For further inquiries related to the webinar or about Ascletis, individuals are encouraged to reach out to the company’s PR and IR teams. They are available to answer questions and provide additional information regarding the products, research efforts, and participation in upcoming events.
Frequently Asked Questions
What is the significance of the upcoming webinar?
The webinar addresses Ascletis’ innovative solutions for obesity, showcasing important developments and clinical data.
Who will present in the webinar?
Dr. Jinzi Jason Wu and John Gargiulo will lead the presentation, followed by a Q&A session.
How can I register for the event?
Registration details will be provided to allow you to secure your attendance at the event.
Will there be a replay available for the webinar?
Yes, an archived replay will be accessible for 30 days following the event.
What areas does Ascletis focus on in terms of R&D?
Ascletis is focused on metabolic diseases and viral diseases, working to develop innovative drug candidates in these fields.
